| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/02/2006 | CN1812797A Use of double-stranded ribonucleic acid for inducing cell lysis |
| 08/02/2006 | CN1812796A Aivlosin for the treatment of disease due to brachyspira pilosicoli or ornithobacterium rhinotracheale |
| 08/02/2006 | CN1812795A Composition for external use |
| 08/02/2006 | CN1812794A Medicinal composition in solution form |
| 08/02/2006 | CN1812793A Sustained drug-relase particles and process for producing the same |
| 08/02/2006 | CN1812792A Use of dipyridamole or mopidamole for treatment and prevention of thromboembolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptors |
| 08/02/2006 | CN1812791A Methods of preventing and reducing the severity of stress-associated conditions |
| 08/02/2006 | CN1812790A 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor |
| 08/02/2006 | CN1812789A Sulfonamide substituted imidazoquinolines |
| 08/02/2006 | CN1812788A Methods of improving skin quality |
| 08/02/2006 | CN1812787A 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors |
| 08/02/2006 | CN1812786A Use of pyrazolopyridines for the treatment of cognitive deficits |
| 08/02/2006 | CN1812785A New effector conjugates, process for their production and their pharmaceutical use |
| 08/02/2006 | CN1812784A New use i |
| 08/02/2006 | CN1812783A Fluconazole containing capsules with improved active ingredient release |
| 08/02/2006 | CN1812782A Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors |
| 08/02/2006 | CN1812781A Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences |
| 08/02/2006 | CN1812780A Cancer treatment with epothilones |
| 08/02/2006 | CN1812779A Compounds for treatment of inflammation, diabetes and related disorders |
| 08/02/2006 | CN1812778A Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions |
| 08/02/2006 | CN1812777A Composition for lowering blood glucose |
| 08/02/2006 | CN1812776A Inhibition of protein kinase c-mu (pkd) as a treatment for cardiac hypertrophy and heart failure |
| 08/02/2006 | CN1812775A Method for inhibiting the growth of antibiotic-resistant of bacteria by using pentane-1,5-diol |
| 08/02/2006 | CN1812768A Pharmaceutical composition and method for treating |
| 08/02/2006 | CN1812767A Method for producing crystals from active ingredients in medicaments, crystals obtained therefrom and the use thereof in pharmaceutical formulations |
| 08/02/2006 | CN1812729A Combinations of vasoprotective agents and formulations containing them |
| 08/02/2006 | CN1810958A Inhibition of nuclear transcription factor NF- kappa B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-n-vanillyl-6-nonenamide) and resiniferatoxin |
| 08/02/2006 | CN1810842A Longleaf Grateloupia acuminata polysaccharide extract and its prepn and use |
| 08/02/2006 | CN1810827A Anticancer prepn containing three anticancer compounds of toad or toad cake and its prepn process |
| 08/02/2006 | CN1810822A 2-aminocarbonyl-9h-purine derivatives |
| 08/02/2006 | CN1810816A Tenoforv monoester compounds with HIV-1/HBV virus copying inhibiting activity |
| 08/02/2006 | CN1810815A Nitroimidazole derivative for treatment |
| 08/02/2006 | CN1810809A Coumarether compound and new use of its composition |
| 08/02/2006 | CN1810805A Synthesis of domperidone maleate |
| 08/02/2006 | CN1810804A Prepn process of [(substituted pyridyl) methyl] sulfenyl-1H-benzimidazole compound and its antimer zinc salt |
| 08/02/2006 | CN1810803A Selective prepn process of (S)-Omeprazole with high antimer |
| 08/02/2006 | CN1810795A Benzopyran compound and its prepn and use |
| 08/02/2006 | CN1810794A Prepn process and medicine composition of dewatered andrographolide |
| 08/02/2006 | CN1810792A Process for producing dibenzo thionitrogen tropilidine derivative |
| 08/02/2006 | CN1810790A Non-metal salt of Glicididazole and its prepn |
| 08/02/2006 | CN1810777A Compound for preventing and treating bacterial infection and its prepn and use |
| 08/02/2006 | CN1810281A Externally applied medicine for preventing and treating piles and health briefs therewith |
| 08/02/2006 | CN1810276A Externally applied medicinal wine for treating rheumatism |
| 08/02/2006 | CN1810275A Pharyngitis treating ointment |
| 08/02/2006 | CN1810274A Cassia, its extract cinnamal and their application in preparing medicine for treating depression |
| 08/02/2006 | CN1810273A Rhinitis treating ointment |
| 08/02/2006 | CN1810268A Apoplexy treating medicine composition |
| 08/02/2006 | CN1810263A Quantum mediated tracking process of preparing medicine for treating diabetes |
| 08/02/2006 | CN1810256A Policresulen foam aerosol and its prepn process |
| 08/02/2006 | CN1810255A Orally taken health article for treating senile dementia |
| 08/02/2006 | CN1810254A New medicinal use of paeonidin |
| 08/02/2006 | CN1810253A Composition of water soluble Azithromycin salt |
| 08/02/2006 | CN1810252A New pharmaceutical use of echinacoside |
| 08/02/2006 | CN1810251A Medicine of treating cerebral ischemia reperfusion injury and its prepn |
| 08/02/2006 | CN1810250A Inclusion compound of porphyrin metal complex and albumin |
| 08/02/2006 | CN1810249A Soft medicine composition capsule and its prepn |
| 08/02/2006 | CN1810248A Application of compound vitamins in preparing medicine for treating tuberculosis |
| 08/02/2006 | CN1810247A Pharmaceutical effect of berbamine derivative EBB in inhibiting invasive metastasis of human body tumor cell |
| 08/02/2006 | CN1810246A Nasal in-situ gel of scopolamine with phase change property |
| 08/02/2006 | CN1810245A Prepn process of Lansoprazole sodium for treating peptic ulcer |
| 08/02/2006 | CN1810244A Freeze dried Lansoprazole sodium injection and its prepn process |
| 08/02/2006 | CN1810243A Hypotensor composition |
| 08/02/2006 | CN1810242A Slow-released vincamine capsule and its prepn process |
| 08/02/2006 | CN1810241A Pharmaceutical use, medicine composition and prepn process of angelica oil components |
| 08/02/2006 | CN1810240A Prepn process and use of total andrographolide emulsion |
| 08/02/2006 | CN1810239A Liver cancer cell inhibitor |
| 08/02/2006 | CN1810238A Oral arginine prepn for preventing and treating cachexia syndrome |
| 08/02/2006 | CN1810237A Slow-released ambroxol salt tablet and its prepn process |
| 08/02/2006 | CN1810236A Liposome preparation of garlicin |
| 08/02/2006 | CN1267727C Ginkgo leaf composition, and preparing method and use thereof |
| 08/02/2006 | CN1267552C Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 08/02/2006 | CN1267457C Method for preparing low molecular weight seaweed polysaccharide sulfate |
| 08/02/2006 | CN1267456C Process for preparing glucose-reducing sand sagebrush polysaccharide and its application |
| 08/02/2006 | CN1267446C Nucleoside derivatives as inhibitors of RNA-dependent PNA viral polymerase |
| 08/02/2006 | CN1267438C antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7h-[1,4] dioxino [2,3-3] indole |
| 08/02/2006 | CN1267437C Pharmaceutical compositions |
| 08/02/2006 | CN1267435C New process for prepn. of oxabispidines |
| 08/02/2006 | CN1267434C Antidepressant (SSSRI) azaheterocyclymethyl derivatives of 7,8-dihydro-3H-6, 9-dioxa-1,3-diazacyclopenta[A] naphthalene |
| 08/02/2006 | CN1267432C 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1h)one derivatives |
| 08/02/2006 | CN1267431C Substituted quinazoline derivatives and their use as inhibitors |
| 08/02/2006 | CN1267430C Triazole compounds with dopamine -D3-receptor affinity |
| 08/02/2006 | CN1267429C Amino alcohol derivatives |
| 08/02/2006 | CN1267427C Process for production of citalopram |
| 08/02/2006 | CN1267424C Piperazinylpyrazine compounds as agonist or antagonist of 5-hydroxytryptamine 5HT-2 receptor |
| 08/02/2006 | CN1267423C Substituted 2-phenylaminomidazoline phenyl ketone derivatives as IP antagonists |
| 08/02/2006 | CN1267421C Antiviral activity possessed compound |
| 08/02/2006 | CN1267420C 药用活性哌啶衍生物 Pharmaceutically active piperidine derivatives |
| 08/02/2006 | CN1267418C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 08/02/2006 | CN1267416C Novel crystals of 5-hydroxycarbamimidoyl-2-hydroxybenzenesulfonamide derivative |
| 08/02/2006 | CN1267412C CCR-3 receptor antagonists V |
| 08/02/2006 | CN1267411C Compound useful as intermediates for cholesteryl ester transfer protein (CETP) inhibitors |
| 08/02/2006 | CN1267408C Compound, compositions and methods for preventing neurodegeneration in acute and chronic injuries in central nervous system |
| 08/02/2006 | CN1267407C Prodrugs of excitatory amino acids |
| 08/02/2006 | CN1267394C Vitamin D analogues |
| 08/02/2006 | CN1267154C Calcium supplementation to reduce prostate cancer risk |
| 08/02/2006 | CN1267126C Chinese medicine for treating coronary heart disease and angina pectoris and its preparation |
| 08/02/2006 | CN1267124C Donky-hide blood-supplementing tonic and its preparation method |
| 08/02/2006 | CN1267114C Midicial herbal compound for prevention and treatment of diabetes |
| 08/02/2006 | CN1267111C Compound red sage drip pill for treating cardiac and cerebral vascular diseases and its prepn process |
| 08/02/2006 | CN1267106C Simethicone/anhydrous calcium phosphate compositions |